Favorable inhibitory effect of clodronate on hepatic steatosis in short bowel syndrome model rats
The high-dose administration of clodronate may, therefore, inhibit hepatic steatosis and inflammation associated with IFALD in patients with SBS.
Authors
- Takafumi Kawano (ORCID: https://orcid.org/0000-0002-5920-453X)
- Nao Hasuzawa (ORCID: https://orcid.org/0000-0003-1344-8667)
- Koshiro Sugita (ORCID: https://orcid.org/0000-0003-4083-8206)
- Satoshi Ieiri
- Masatoshi Nomura
- Keisuke Yano (ORCID: https://orcid.org/0000-0003-0417-3104)
- Chihiro Kedoin
- Yudai Tsuruno (ORCID: https://orcid.org/0009-0000-6830-2732)
- Masakazu Murakami (ORCID: https://orcid.org/0000-0002-9247-4216)
- Yuko Bitoh (ORCID: https://orcid.org/0000-0002-0691-866X)
- Shun Onishi (ORCID: https://orcid.org/0000-0002-3984-3764)
- Ayaka Nagano
- Tatsuru Kaji
- Yumiko Tabata
Institutions
- Kurume University (JP)
- Kagoshima University (JP)
- Kobe University (JP)
Publication Details
- Journal
- Pediatric Surgery International
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1007/s00383-024-05858-y
- Citations
- 3
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.93
Funders
- Kagoshima University
- Japan Society for the Promotion of Science